临床试验的多样性:一个复杂的问题,而不是一个简单的解决方案
1Division of General Internal Medicine, Albert Einstein College of Medicine, Bronx, NY.
概括
这次演讲强调了美国糖尿病协会在医疗保健和教育方面的举措. 它讨论了糖尿病管理和研究的关键进展和未来方向.
科学领域:
- 糖尿病 护理 糖尿病 护理
- 公共卫生倡议 公共卫生倡议
- 医学研究 医学研究
背景情况:
- 美国糖尿病协会 (ADA) 在促进糖尿病护理方面发挥着关键作用.
- 医疗保健和教育总裁在2023年6月发表了重要讲话.
- 这次演讲是在ADA第83届科学会议上发表的.
研究的目的:
- 要总结ADA目前的医疗保健和教育战略.
- 概述糖尿病研究和患者支持的未来方向.
- 为了从ADA总统的演讲中提供见解.
主要方法:
- 总统演讲的改编,以便更广泛地传播.
- 在糖尿病的背景下,专注于医疗保健和教育.
- 利用ADA第83届科学会议作为一个平台.
主要成果:
- 介绍了糖尿病医疗保健的关键举措.
- 讨论了患者和专业人员的教育策略.
- 突出了未来的研究重点.
结论:
- 美国糖尿病协会致力于改善糖尿病医疗保健和教育.
- 持续创新对于管理和潜在地治愈糖尿病至关重要.
- 这次演讲为ADA正在进行的努力提供了路线图.
更多相关视频
07:54Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence
Published on: October 25, 2011
18.6K
14:45Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay
Published on: September 16, 2012
15.0K
相关概念视频
01:16Clinical Trials
6.7K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.7K
01:11Clinical Trials: Overview
2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
125
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
125
01:12Hazard Ratio
115
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
115
01:28Preclinical Development: Overview
4.4K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.4K
01:11Blinding
2.4K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.4K